Mundipharma Signs Major Agreement with Kolon Life Sciences to Bring World's First Gene Therapy for Knee Osteoarthritis to Japan

TOKYO, Nov. 19, 2018 /PRNewswire/ -- In a multi-year agreement for up to USD 600 million, Mundipharma has acquired the exclusive rights for Invossa ® in Japan from Kolon Life Sciences. Invossa ...